The relationship between hemodialysis mortality and the Chinese medical insurance type

Xi Yao1,2, Shaohua Chen1,2, Wenhua Lei1,2

  • 1Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Renal Failure
|December 28, 2019
PubMed

Insights

Patients with the New Cooperative Medical Scheme (NCMS) had higher mortality in hemodialysis (HD) compared to those with Urban Basic Medical Insurance (UBMI). NCMS is independently associated with increased mortality for HD patients in China.

Area of Science:

  • Nephrology
  • Public Health
  • Health Economics

Background:

  • China has two primary medical insurance models: Urban Basic Medical Insurance (UBMI) and the New Cooperative Medical Scheme (NCMS).
  • Understanding the impact of these insurance models on patient outcomes is crucial for healthcare policy and patient care.

Purpose of the Study:

  • To evaluate the association between medical insurance type and survival rates in patients undergoing hemodialysis (HD).
  • To compare the clinical characteristics and outcomes of patients with UBMI versus NCMS.

Main Methods:

  • Retrospective analysis of adult end-stage renal disease patients initiating HD between 2010-2014 in Zhejiang province.
  • Kaplan-Meier survival analysis and multivariate Cox proportional hazards modeling were used to compare outcomes between UBMI and NCMS groups.

Main Results:

  • A total of 13,956 patients (6779 UBMI, 7177 NCMS) were analyzed.
  • Patients with NCMS exhibited poorer clinical profiles, including higher rates of anemia, hypoalbuminemia, and calcium/phosphorous metabolism issues.
  • The 5-year survival rate was significantly lower for NCMS patients (67.7%) compared to UBMI patients (74.1%).
  • NCMS was independently associated with a 53% increase in all-cause mortality (AHR = 1.53).

Conclusions:

  • Medical insurance type significantly impacts survival outcomes for patients on maintenance hemodialysis in China.
  • The New Cooperative Medical Scheme (NCMS) is linked to increased mortality risk compared to Urban Basic Medical Insurance (UBMI).
  • Findings suggest a need to address disparities in care or coverage associated with different insurance models to improve HD patient survival.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
499
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
135
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
631
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
505